How do I safely switch from 75mg of one SSRI (Selective Serotonin Reuptake Inhibitor) to 25mg of another SSRI for an adult patient with a history of depression or anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Switch from 75mg SSRI to 25mg SSRI

Use a direct cross-taper approach over 3-7 days: reduce your current 75mg SSRI by 50% while simultaneously starting the new SSRI at 25mg, then discontinue the original SSRI completely after this brief overlap period while maintaining or increasing the new SSRI dose as tolerated. 1

Specific Switching Protocol

Week 1: Initial Cross-Taper

  • Start the new SSRI at 25mg daily while reducing your current 75mg SSRI to approximately 37.5mg (50% reduction) 1
  • Maintain both medications at these doses for 3-7 days 1
  • This overlap period minimizes discontinuation syndrome from the first SSRI while allowing gradual introduction of the second 2

Week 2: Complete the Switch

  • Discontinue the original 75mg SSRI completely after the 3-7 day overlap 1
  • Continue the new SSRI at 25mg, or increase to target therapeutic dose (typically 50-200mg depending on the specific SSRI) as tolerated 1
  • The dose escalation should occur over the following week based on tolerability 1

Critical Safety Monitoring

First Week Surveillance

  • Contact your prescriber within the first week to assess tolerability and adherence 1
  • Monitor closely for serotonin syndrome symptoms: agitation, confusion, tremors, hyperreflexia, autonomic instability, especially in the first 24-48 hours after starting the overlap 3, 4
  • Watch for common SSRI initiation side effects: gastrointestinal symptoms, insomnia, nervousness, tremors 1

Discontinuation Syndrome Warning

  • Never abruptly stop the 75mg SSRI without tapering, as this causes discontinuation syndrome with dizziness, fatigue, muscle aches, nausea, insomnia, anxiety, and sensory disturbances 4, 2
  • The gradual 3-7 day taper minimizes this risk significantly 1

Expected Outcomes and Follow-Up

  • Assess therapeutic response at 4-6 weeks after reaching the target dose of the new SSRI 1
  • Evidence shows no significant efficacy differences between different SSRIs when switched appropriately, so expect similar antidepressant/anxiolytic effects 1, 5
  • Moderate-quality evidence confirms that switching from one SSRI to another shows similar outcomes to continuing the same medication 5, 1

Absolute Contraindications

  • Never combine SSRIs with MAOIs - both the old and new SSRI are contraindicated with monoamine oxidase inhibitors 1, 4
  • Ensure no MAOI use within 14 days before or after any SSRI switch 4

Common Pitfalls to Avoid

  • Do not start the new SSRI at high doses - higher starting doses increase risk of behavioral activation and suicide-related events 1
  • Do not use a prolonged washout period between SSRIs - this creates unnecessary periods without treatment and risks depressive/anxiety exacerbation 2, 6
  • Do not assume you need to wait weeks between medications - direct cross-tapering is the recommended approach for SSRI-to-SSRI switches 1, 6

References

Guideline

Switching from Escitalopram to Sertraline: A Guideline Summary

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Switching and stopping antidepressants.

Australian prescriber, 2016

Guideline

Switching from Sertraline to Duloxetine or Venlafaxine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.